Sex differences in type 2 diabetes: focus on disease course and outcomes
Lisa Arnetz,1,2 Neda Rajamand Ekberg,1,2 Michael Alvarsson1,2 1Department of Molecular Medicine and Surgery, Karolinska Institutet, 2Department of Endocrinology, Metabolism and Diabetes, Stockholm, Sweden Background: Women with type 2 diabetes (T2D) are less likely to reach the goals for hemoglobi...
Saved in:
Main Authors: | Arnetz L, Ekberg NR, Alvarsson M |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/fdd2dd7c0ce64d25b5d0457bd398e3f8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging DPP-4 inhibitors: focus on linagliptin for type 2 diabetes
by: Gallwitz B
Published: (2013) -
Use of DPP-4 inhibitors in type 2 diabetes: focus on sitagliptin
by: Bo Ahrén
Published: (2010) -
Management of diabetes across the course of disease: minimizing obesity-associated complications
by: Apovian CM
Published: (2011) -
Sexual dysfunction in diabetic women: prevalence and differences in type 1 and type 2 diabetes mellitus
by: Mazzilli R, et al.
Published: (2015) -
SGLT2 inhibitors – an insulin-independent therapeutic approach for treatment of type 2 diabetes: focus on canagliflozin
by: Seufert J
Published: (2015)